Management

Expertise, insight and commitment to deliver on strategy

Opus’ core team has an ideal mix of experience in science, company formation, patient advocacy, financing and gene therapy drug development. 

Management

Ben Yerxa, PhD
Chief Executive Officer
Ash Jayagopal, PhD
Chief Scientific Officer
Joe Schachle
Chief Operating Officer
Nikki Heron
Chief Financial Officer
Jennifer Hunt
Chief Development Officer
Brian Leising
Vice President of Manufacturing
Vikram Arora, PhD, DABT
Vice President of Non-Clinical Development
Erin O’Neil, MD
Vice President of Clinical Development
Sarah Tuller, JD, RAC
Vice President of Regulatory Affairs and Medical Writing